Respiratory syncytial virus infection alters surfactant protein A expression in human pulmonary epithelial cells by reducing translation efficiency

American Journal of Physiology - Lung Cellular and Molecular Physiology

Volumn 297, Issue 4, 2009, Pages

  Bruce, Shirley R ^a   Atkins, Constance L ^a   Colasurdo, Giuseppe N ^a   Alcorn, Joseph L ^a  

^a UNIVERSITY OF TEXAS MEDICAL SCHOOL   (United States)

Author keywords

Collectin; Posttranscriptional regulation; Ubiquitination

Indexed keywords

BETA ACTIN; COLLECTIN; CYCLOPHILIN; MESSENGER RNA; PROTEASOME; SURFACTANT PROTEIN A;

ARTICLE; CLARA CELL; CLEARANCE; CONTROLLED STUDY; CYTOPLASM; ENZYME ACTIVITY; HOST RESISTANCE; HUMAN; HUMAN CELL; INNATE IMMUNITY; LUNG ALVEOLUS CELL TYPE 2; LUNG ALVEOLUS EPITHELIUM; NONHUMAN; POLYSOME; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN EXPRESSION; PROTEIN SECRETION; PROTEIN SYNTHESIS; RESPIRATORY SYNCYTIAL PNEUMOVIRUS; RNA TRANSLATION; STEADY STATE; UBIQUITINATION; VIRUS INFECTION;

BLOTTING, NORTHERN; CELL NUCLEUS; CELLS, CULTURED; EPITHELIAL CELLS; HUMANS; IMMUNOBLOTTING; IMMUNOPRECIPITATION; INTERFERON-GAMMA; LUNG; POLYRIBOSOMES; PROTEIN BIOSYNTHESIS; PULMONARY SURFACTANT-ASSOCIATED PROTEIN A; RESPIRATORY SYNCYTIAL VIRUS INFECTIONS; RESPIRATORY SYNCYTIAL VIRUS, HUMAN; RNA STABILITY; RNA, MESSENGER; UBIQUITINATION;

EID: 70349761457     PISSN: 10400605     EISSN: 15221504     Source Type: Journal    
DOI: 10.1152/ajplung.90507.2008     Document Type: Article

References (66)

1. Abramson JS, Wheeler JG. Virus-induced neutrophil dysfunction: role in the pathogenesis of bacterial infections. Pediatr Infect Dis J 13: 643-652, 1994.
2. Al-Darraji AM, Cutlip RC, Lehmkuhl HD, Graham DL, Kluge JP, Frank GH. Experimental infection of lambs with bovine respiratory syncytial virus and Pasteurella haemolytica: clinical and microbiologic studies. Am J Vet Res 43: 236-240, 1982.
3. Alcorn JL, Smith ME, Smith JF, Margraf LR, Mendelson CR. Primary cell culture of human type II pneumonocytes: maintenance of a differentiated phenotype and transfection with recombinant adenoviruses. Am J Respir Cell Mol Biol 17: 672-682, 1997.
4. Alcorn JL, Stark JM, Chiappetta CL, Jenkins G, Colasurdo GN. Effects of RSV infection on pulmonary surfactant protein SP-A in cultured human type II cells: contrasting consequences on SP-A mRNA and protein. Am J Physiol Lung Cell Mol Physiol 289: L1113-L1122, 2005. (Pubitemid 41681346)
5. Alonso-Caplen FV, Nemeroff ME, Qiu Y, Krug RM. Nucleocytoplasmic transport: the influenza virus NS1 protein regulates the transport of spliced NS2 mRNA and its precursor NS1 mRNA. Genes Dev 6: 255-267, 1992.
6. Brower M, Carney DN, Oie HK, Gazdar AF, Minna JD. Growth of cell lines and clinical specimens of human non-small cell lung cancer in a serum-free defined medium. Cancer Res 46: 798-806, 1986. (Pubitemid 16145440)
7. Carter MS, Li S, Wilkinson MF. A splicing-dependent regulatory mechanism that detects translation signals. EMBO J 15: 5965-5975, 1996. (Pubitemid 26375518)
8. Chen TR. Re-evaluation of HeLa, HeLa S3, and HEp-2 karyotypes. Cytogenet Cell Genet 48: 19-24, 1988.
9. Cheng KT, Huang YC, Lin YS, Su B, Chen CM. Effects of baicalin on the gene expression of surfactant protein A (SP-A) in lung adenocarcinoma cell line H441. Planta Med 69: 300-304, 2003. (Pubitemid 36577993)
10. Clements J, King R. The Biochemical Basis of Pulmonary Function. New York: Dekker, 1976.
11. Crouch E, Wright JR. Surfactant proteins A and D and pulmonary host defense. Annu Rev Physiol 63: 521-554, 2001. (Pubitemid 32304328)
12. Crouch EC. Collectins and pulmonary host defense. Am J Respir Cell Mol Biol 19: 177-201, 1998.
13. Denny FW, Clyde WA Jr. Acute lower respiratory tract infections in nonhospitalized children. J Pediatr 108: 635-646, 1986. (Pubitemid 16064102)
14. Domachowske JB, Rosenberg HF. Respiratory syncytial virus infection: immune response, immunopathogenesis, and treatment. Clin Microbiol Rev 12: 298-309, 1999. (Pubitemid 29196855)
15. Englund JA, Sullivan CJ, Jordan MC, Dehner LP, Vercellotti GM, Balfour HH Jr. Respiratory syncytial virus infection in immunocompromised adults. Ann Intern Med 109: 203-208, 1988. (Pubitemid 18237042)
16. Fortes P, Beloso A, Ortin J. Influenza virus NS1 protein inhibits pre-mRNA splicing and blocks mRNA nucleocytoplasmic transport. EMBO J 13: 704-712, 1994. (Pubitemid 24050686)
17. Foy HM, Cooney MK, Maletzky AJ, Grayston JT. Incidence and etiology of pneumonia, croup and bronchiolitis in preschool children belonging to a prepaid medical care group over a four-year period. Am J Epidemiol 97: 80-92, 1973.
18. Gazdar AF, Linnoila RI, Kurita Y, Oie HK, Mulshine JL, Clark JC, Whitsett JA. Peripheral airway cell differentiation in human lung cancer cell lines. Cancer Res 50: 5481-5487, 1990. (Pubitemid 20303008)
19. Ghildyal R, Hartley C, Varrasso A, Meanger J, Voelker DR, Anders EM, Mills J. Surfactant protein A binds to the fusion glycoprotein of respiratory syncytial virus and neutralizes virion infectivity. J Infect Dis 180: 2009-2013, 1999.
20. Griffin MR, Coffey CS, Neuzil KM, Mitchel EF Jr, Wright PF, Edwards KM. Winter viruses: influenza- and respiratory syncytial virus-related morbidity in chronic lung disease. Arch Intern Med 162: 1229-1236, 2002.
21. Haagsman HP, Diemel RV. Surfactant-associated proteins: functions and structural variation. Comp Biochem Physiol A Mol Integr Physiol 129: 91-108, 2001. (Pubitemid 32455709)
22. Hacking D, Hull J. Respiratory syncytial virus-viral biology and the host response. J Infect 45: 18-24, 2002. (Pubitemid 36104802)
23. Hall CB, Douglas RG Jr, Geiman JM. Quantitative shedding patterns of respiratory syncytial virus in infants. J Infect Dis 132: 151-156, 1975.
24. Hawgood S, Poulain FR. The pulmonary collectins and surfactant metabolism. Annu Rev Physiol 63: 495-519, 2001.
25. Holberg CJ, Wright AL, Martinez FD, Ray CG, Taussig LM, Lebowitz MD. Risk factors for respiratory syncytial virus-associated lower respiratory illnesses in the first year of life. Am J Epidemiol 133: 1135-1151, 1991.
26. Holmskov U, Thiel S, Jensenius JC. Collections and ficolins: humoral lectins of the innate immune defense. Annu Rev Immunol 21: 547-578, 2003. (Pubitemid 37174541)
27. Hoover RR, Floros J. SP-A 3′-UTR is involved in the glucocorticoid inhibition of human SP-A gene expression. Am J Physiol Lung Cell Mol Physiol 276: L917-L924, 1999. (Pubitemid 29321168)
28. Huang HY, Chien CH, Jen KH, Huang HD. RegRNA: an integrated web server for identifying regulatory RNA motifs and elements. Nucleic Acids Res 34: W429-W434, 2006.
29. Ilkow CS, Mancinelli V, Beatch MD, Hobman TC. Rubella virus capsid protein interacts with poly(A)-binding protein and inhibits translation. J Virol 82: 4284-4294, 2008. (Pubitemid 351563666)
30. Imataka H, Gradi A, Sonenberg N. A newly identified N-terminal amino acid sequence of human eIF4G binds poly(A)-binding protein and functions in poly(A)-dependent translation. EMBO J 17: 7480-7489, 1998. (Pubitemid 29002714)
31. Kahvejian A, Svitkin YV, Sukarieh R, M'Boutchou MN, Sonenberg N. Mammalian poly(A)-binding protein is a eukaryotic translation initiation factor, which acts via multiple mechanisms. Genes Dev 19: 104-113, 2005. (Pubitemid 40095820)
32. Kao YJ, Piedra PA, Larsen GL, Colasurdo GN. Induction and regulation of nitric oxide synthase in airway epithelial cells by respiratory syncytial virus. Am J Respir Crit Care Med 163: 532-539, 2001. (Pubitemid 32158541)
33. Kerr MH, Paton JY. Surfactant protein levels in severe respiratory syncytial virus infection. Am J Respir Crit Care Med 159: 1115-1118, 1999. (Pubitemid 29202544)
34. Korppi M, Koskela M, Jalonen E, Leinonen M. Serologically indicated pneumococcal respiratory infection in children. Scand J Infect Dis 24: 437-443, 1992.
35. Korppi M, Leinonen M, Koskela M, Makela PH, Launiala K. Bacterial coinfection in children hospitalized with respiratory syncytial virus infections. Pediatr Infect Dis J 8: 687-692, 1989. (Pubitemid 19253584)
36. LeVine AM, Whitsett JA, Gwozdz JA, Richardson TR, Fisher JH, Burhans MS, Korfhagen TR. Distinct effects of surfactant protein A or D deficiency during bacterial infection on the lung. J Immunol 165: 3934-3940, 2000.
37. Levine S, Klaiber-Franco R, Paradiso PR. Demonstration that glycoprotein G is the attachment protein of respiratory syncytial virus. J Gen Virol 68: 2521-2524, 1987. (Pubitemid 17129228)
38. Li S, Leonard D, Wilkinson MF. T cell receptor (TCR) mini-gene mRNA expression regulated by nonsense codons: a nuclear-associated translation-like mechanism. J Exp Med 185: 985-992, 1997. (Pubitemid 27136791)
39. Mazumder B, Fox PL. Delayed translational silencing of ceruloplasmin transcript in gamma interferon-activated U937 monocytic cells: role of the 3′ untranslated region. Mol Cell Biol 19: 6898-6905, 1999. (Pubitemid 29441872)
40. Mazumder B, Mukhopadhyay CK, Prok A, Cathcart MK, Fox PL. Induction of ceruloplasmin synthesis by IFN-gamma in human monocytic cells. J Immunol 159: 1938-1944, 1997.
41. Mikerov AN, Umstead TM, Huang W, Liu W, Phelps DS, Floros J. SP-A1 and SP-A2 variants differentially enhance association of Pseudomonas aeruginosa with rat alveolar macrophages. Am J Physiol Lung Cell Mol Physiol 288: L150-L158, 2005. (Pubitemid 40023897)
42. Mikerov AN, Wang G, Umstead TM, Zacharatos M, Thomas NJ, Phelps DS, Floros J. Surfactant protein A2 (SP-A2) variants expressed in CHO cells stimulate phagocytosis of Pseudomonas aeruginosa more than do SP-A1 variants. Infect Immun 75: 1403-1412, 2007. (Pubitemid 46385834)
43. Moore AE, Sabachewsky L, Toolan HW. Culture characteristics of four permanent lines of human cancer cells. Cancer Res 15: 598-602, 1955.
44. Mufson MA, Krause HE, Mocega HE, Dawson FW. Viruses, Mycoplasma pneumoniae and bacteria associated with lower respiratory tract disease among infants. Am J Epidemiol 91: 192-202, 1970.
45. Mufson MA, Levine HD, Wasil RE, Mocega-Gonzalez HE, Krause HE. Epidemiology of respiratory syncytial virus infection among infants and children in Chicago. Am J Epidemiol 98: 88-95, 1973.
46. Nandi D, Tahiliani P, Kumar A, Chandu D. The ubiquitin-proteasome system. J Biosci 31: 137-155, 2006.
47. Nohynek H, Eskola J, Laine E, Halonen P, Ruutu P, Saikku P, Kleemola M, Leinonen M. The causes of hospital-treated acute lower respiratory tract infection in children. Am J Dis Child 145: 618-622, 1991.
48. O'Donnell KA, Wentzel EA, Zeller KI, Dang CV, Mendell JT. c-Myc-regulated microRNAs modulate E2F1 expression. Nature 435: 839-843, 2005.
49. O'Reilly MA, Gazdar AF, Clark JC, Pilot-Matias TJ, Wert SE, Hull WM, Whitsett JA. Glucocorticoids regulate surfactant protein synthesis in a pulmonary adenocarcinoma cell line. Am J Physiol Lung Cell Mol Physiol 257: L385-L392, 1989.
50. O'Reilly P, Hickman-Davis JM, McArdle P, Young KR, Matalon S. The role of nitric oxide in lung innate immunity: modulation by surfactant protein-A. Mol Cell Biochem 234-235: 39-48, 2002. (Pubitemid 34777840)
51. Olsen PH, Ambros V. The lin-4 regulatory RNA controls developmental timing in Caenorhabditis elegans by blocking LIN-14 protein synthesis after the initiation of translation. Dev Biol 216: 671-680, 1999. (Pubitemid 30013313)
52. Parrott RH, Kim HW, Arrobio JO, Hodes DS, Murphy BR, Brandt CD, Camargo E, Chanock RM. Epidemiology of respiratory syncytial virus infection in Washington, DC. II. Infection and disease with respect to age, immunologic status, race and sex. Am J Epidemiol 98: 289-300, 1973.
53. Patel J, Faden H, Sharma S, Ogra PL. Effect of respiratory syncytial virus on adherence, colonization and immunity of non-typable Haemophilus influenzae: implications for otitis media. Int J Pediatr Otorhinolaryngol 23: 15-23, 1992.
54. Qiu Y, Krug RM. The influenza virus NS1 protein is a poly(A)-binding protein that inhibits nuclear export of mRNAs containing poly(A). J Virol 68: 2425-2432, 1994. (Pubitemid 24091922)
55. Qiu Y, Nemeroff M, Krug RM. The influenza virus NS1 protein binds to a specific region in human U6 snRNA and inhibits U6-U2 and U6-U4 snRNA interactions during splicing. RNA 1: 304-316, 1995.
56. Sampath P, Mazumder B, Seshadri V, Fox PL. Transcript-selective translational silencing by gamma interferon is directed by a novel structural element in the ceruloplasmin mRNA 3′ untranslated region. Mol Cell Biol 23: 1509-1519, 2003. (Pubitemid 36246034)
57. Scavo LM, Ertsey R, Gao BQ. Human surfactant proteins A1 and A2 are differentially regulated during development and by soluble factors. Am J Physiol Lung Cell Mol Physiol 275: L653-L669, 1998. (Pubitemid 28491847)
58. Seggerson K, Tang L, Moss EG. Two genetic circuits repress the Caenorhabditis elegans heterochronic gene lin-28 after translation initiation. Dev Biol 243: 215-225, 2002. (Pubitemid 34218925)
59. Shay DK, Holman RC, Newman RD, Liu LL, Stout JW, Anderson LJ. Bronchiolitis-associated hospitalizations among US children, 1980-1996. JAMA 282: 1440-1446, 1999.
60. Shay DK, Holman RC, Roosevelt GE, Clarke MJ, Anderson LJ. Bronchiolitis-associated mortality and estimates of respiratory syncytial virus-associated deaths among US children, 1979-1997. J Infect Dis 183: 16-22, 2001.
61. Thompson WW, Shay DK, Weintraub E, Brammer L, Cox N, Anderson LJ, Fukuda K. Mortality associated with influenza and respiratory syncytial virus in the United States. JAMA 289: 179-186, 2003. (Pubitemid 36068705)
62. Tino MJ, Wright JR. Surfactant protein A stimulates phagocytosis of specific pulmonary pathogens by alveolar macrophages. Am J Physiol Lung Cell Mol Physiol 270: L677-L688, 1996. (Pubitemid 26148342)
63. Tripp RA. Pathogenesis of respiratory syncytial virus infection. Viral Immunol 17: 165-181, 2004. (Pubitemid 38880419)
64. Walsh EE, Hruska J. Monoclonal antibodies to respiratory syncytial virus proteins: identification of the fusion protein. J Virol 47: 171-177, 1983.
65. Wang G, Guo X, Floros J. Differences in the translation efficiency and mRNA stability mediated by 5′-UTR splice variants of human SP-A1 and SP-A2 genes. Am J Physiol Lung Cell Mol Physiol 289: L497-L508, 2005. (Pubitemid 41192726)
66. Wright JR, Youmans DC. Pulmonary surfactant protein A stimulates chemotaxis of alveolar macrophage. Am J Physiol Lung Cell Mol Physiol 264: L338-L344, 1993. (Pubitemid 23125309)